BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)BALA CYNWYD, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Boston Scientific: Why This MedTech Giant Isn’t Slowing DownBoston Scientific Co (
NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?Surgical robotics company PROCEPT BioRobotics Co. (
NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia
Medical Technology Stock Benefits from Rising Acute Care DemandMedical and surgical products manufacturer Stryker Co. (
NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry.
Why Intuitive Surgical Stock is Dominating the Medical SectorRobotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However
Intuitive Surgical Leads the Robotic Surgery MovementIntuitive Surgical is the pioneer in robotic-assisted surgery, investors hope the fifth generation of its da Vinci system can push ISRG stock higher
Hidden gems: 3 undervalued stocks with a unique competitive edgeEtsy, International Flavors & Fragrances and Zimmer Biomet are undervalued stocks with unique market advantages. Patient investors may find opportunities here.
Is the Ozempic-Driven DexCom Selloff Overdone?Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly?
3 Undervalued Healthcare Stocks to Watch as Sector StrugglesAs the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings GrowthDexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next.
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical DemandSurgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers.
Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers HigherShockwave got a 10.64% jolt on a proposed Medicare change that could up the usage of its gear. Other medical product makers are forming bullish consolidations.
Zimmer Biomet Beats on Earnings, Growth May be Priced InZimmer Biomet stock is gaining after beating expectations. However, ZBH stock was fairly valued before earnings meaning investors may need to wait on analysts
Is Zimmer Biomet a Buy Ahead of Earnings?Zimmer will report Q4'22 earnings this week. The question on people's minds is if it's a buy prior to this announcement being made.
